Clough Capital Partners’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-173,010
Closed -$2.82M 127
2026
Q1
$2.82M Hold
173,010
0.27% 54
2025
Q4
$2.57M Buy
+173,010
New +$2.45M 0.23% 60
2024
Q4
Sell
-320,967
Closed -$6.03M 159
2024
Q3
$6.03M Sell
320,967
-108,530
-25% -$2.08M 0.62% 50
2024
Q2
$8.11M Sell
429,497
-156,969
-27% -$2.68M 0.89% 43
2024
Q1
$9.53M Sell
586,466
-2,072
-0.4% -$30.3K 1.05% 40
2023
Q4
$7.45M Sell
588,538
-59,020
-9% -$745K 0.82% 42
2023
Q3
$8.82M Buy
647,558
+93,542
+17% +$1.44M 0.95% 38
2023
Q2
$9.51M Buy
554,016
+1,856
+0.3% +$28.8K 0.96% 33
2023
Q1
$7.69M Buy
+552,160
New +$8.13M 0.83% 43
2015
Q3
Sell
-1,521,517
Closed -$13.3M 220
2015
Q2
$13.3M Sell
1,521,517
-21,344
-1% -$179K 0.51% 75
2015
Q1
$12.3M Sell
1,542,861
-114,330
-7% -$854K 0.41% 93
2014
Q4
$12.9M Buy
+1,657,191
New +$12.1M 0.46% 86

Other funds holding SEM

Clough Capital Partners's SEM Position: Q2 2026 in Review

Clough Capital Partners sold out of Select Medical (SEM) in Q2 2026, closing a stake of 173,010 shares — an estimated $2.82M sold.

Clough Capital Partners first reported a position in SEM in Q4 2014 and held it in 12 quarters. The position peaked at $13.3M in Q2 2015. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Clough Capital Partners reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
  • Clough Capital Partners sold 173,010 Select Medical shares in Q2 2026, an estimated $2.82M.
  • Clough Capital Partners first reported a position in Select Medical in Q4 2014 and held it in 12 quarters.
  • Clough Capital Partners's Select Medical position peaked at $13.3M in Q2 2015.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Clough Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.